HEHossein Estiri

Hossein Estiri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hossein Estiri has a total of 287 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    i2b2-ML: module to facilitate machine learning in the informatics for integrating biology and the bedside platform

    by Jeffery G Klann, Micheal M Mendis, Shyam Visweswaran, Shawn N Murphy, Hossein Estiri, Kavishwar B Wagholikar

    Although machine learning (ML) holds significant potential to transform healthcare, there has been a recent surge in research output that often lacks methodological rigor, contributing to a reproducibility crisis. Additionally, the growing reliance on electronic health records (EHR) for developing ML models has heightened concerns about patient data privacy. To tackle these challenges, we have extended the open-source i2b2 (Informatics for Integrating Biology and the Bedside) platform to allow researchers to train and run ML models without requiring manual programming or direct access to patient-level data. We have developed a proof-of-concept ML module for the i2b2 platform for creating and executing ML models. We describe the design of the module and demonstrate its use on a publicly available Kaggle dataset. Next we test its scalability on a large real-world dataset. Model training with EHR of 100,000 patients randomly selected from the MIMIC-IV dataset was completed in 75.8 minutes and the developed model was applied to classify 28,985 patients in 1.61 minutes. Implementation of the ML functionalities of the i2b2-ML module was successfully evaluated with a publicly available dataset. The developed module allows seamless training and execution of ML models without the need for manual programming and export of patient-level data, thus addressing many of the challenges associated with data privacy and reproducibility. In summary, the developed i2b2-ML module can reduce the technical overhead for researchers for applying ML to health data. Future work will focus on improving the i2b2 graphical interface to further simplify the use of the ML module and on streamlining the distribution of the ML module to existing i2b2 installations, so researchers can more easily analyze EHR data that exists in their current installations.

  • Beyond human-initiated screening: the imperative for fully autonomous brain health surveillance

    by Neguine Rezaii, Hossein Estiri

    Rezaii and Estiri argue that standard cognitive screening is too infrequent, burdensome, and costly to detect most cases of early Alzheimer's disease. They suggest that autonomous AI, passively reviewing routine medical notes and patient speech at near-zero cost, could enable proactive early detection for timely intervention.

  • Top Cited Papers
    Open Access

    Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

    by Jiazi Tian, Alaleh Azhir, Matthew Decaro, Ngan Chau, Jonas Hügel, Michele Morris, Jingya Cheng, Pedram Fard, Ingrid V. Bassett, Douglas S. Bell, et al.

    Importance: Surveillance of postacute sequelae of SARS-CoV-2 infection (PASC) depends on diagnostic coding systems that capture fewer than one-half of affected individuals, rendering millions invisible to health systems and policymakers. Objective: To quantify the gap between true PASC burden and diagnostic code–based estimates, determine the proportion representing chronic disease, and characterize organ system heterogeneity and temporal trends across diverse populations. Design, Setting, and Participants: This retrospective cohort study used electronic health record data from 58 hospitals and affiliated clinics in 4 US regions, from 2017 to 2025. Adults (aged ≥18 years) with laboratory-confirmed SARS-CoV-2 infection or a COVID-19 diagnosis code were included. A custom artificial intelligence algorithm, the Precision Phenotyping for Research Cohorts (P2RC), was implemented using federated infrastructure. Exposure: Laboratory-confirmed SARS-CoV-2 infection or COVID-19 diagnosis code. Main Outcomes and Measures: The primary outcomes were PASC prevalence, the proportion classified as chronic conditions, organ system distribution, and temporal trends from 2020 to 2024. χ 2 Tests were used to assess organ system heterogeneity across regions, and negative binomial regression was used to model quarterly temporal trends, yielding incidence rate ratios (IRRs) with 95% CIs. Results: In this cohort study of 457 950 COVID-19 cases (mean age, 52.05 years; 275 107 [60.07%] female), the P2RC algorithm identified 74 560 PASC cases (16.28% overall; 28 585 [18.58%] in New England, 978 [19.55%] in Southeast Texas, 10 534 [22.69%] in Southern California, and 34 463 [13.64%] in Western Pennsylvania), more than 2-fold higher than the proportion identified by code-based surveillance (International Statistical Classification of Diseases, Tenth Revision, Clinical Modification codes associated with PASC, 594 (67.27%) represented chronic or potentially chronic conditions. Of 74 560 patients with PASC, 66 587 (89.31%) developed chronic conditions requiring ongoing clinical management; this represents 14.54% of the total number of 457 950 patients with COVID-19. Substantial organ system heterogeneity was observed (χ 2 = 2504.73; P < .001): New England demonstrated thyroid-predominant endocrine patterns, while Southeast Texas, Southern California, and Western Pennsylvania showed metabolic-predominant profiles. Negative binomial regression revealed increasing PASC prevalence through mid-2024 (IRR per quarter, 1.01 [95% CI, 1.00-1.01; P < .001] in New England; 1.00 [95% CI, 1.00-1.01; P < .001] in Southern California; and 1.02 [95% CI, 1.01-1.02; P < .001] in Western Pennsylvania), indicating an accumulating rather than resolving burden. Conclusions and Relevance: In this cohort study, approximately 1 in 6 patients with COVID-19 developed PASC, and 89.31% of these patients had at least 1 chronic condition. Current diagnostic coding captured fewer than one-half of the cases, obscuring a substantial chronic disease burden. The persistently increasing prevalence through 2024 indicated an accumulating health care burden requiring investment in surveillance infrastructure and integrated care pathways.


  • Open Access

    Temporal Learning with Dynamic Range (TLDR) for modeling recurrent exposure and treatment outcomes

    by Jingya Cheng, Jonas Hügel, Jiazi Tian, Alaleh Azhir, Shawn N. Murphy, Jeffrey G. Klann, Hossein Estiri

    The temporal sequence of clinical events is crucial in outcomes research, yet standard machine learning (ML) approaches often overlook this aspect in electronic health records (EHRs), limiting predictive accuracy. We introduce Temporal Learning with Dynamic Range (TLDR), a time-sensitive ML framework, to identify risk factors for post-acute sequelae of SARS-CoV-2 infection (PASC). Using longitudinal EHR data from over 85,000 patients in the Precision PASC Research Cohort (P2RC) from a large integrated academic medical center, we compare TLDR against a conventional atemporal ML model. TLDR demonstrated superior predictive performance, achieving a mean AUROC of 0.791 compared to 0.668 for the benchmark, marking an 18.4% improvement. Additionally, TLDR’s mean PRAUC of 0.590 significantly outperformed the benchmark’s 0.421, a 40.14% increase. The framework exhibited improved generalizability with a lower mean overfitting index (− 0.028), highlighting its robustness. Beyond predictive gains, TLDR’s use of time-stamped features enhanced interpretability, offering a more precise characterization of individual patient records. TLDR effectively captures exposure–outcome associations and offers flexibility in time-stamping strategies to suit diverse clinical research needs. TLDR provides a simple yet effective approach for integrating dynamic temporal windows into predictive modeling. It is available within the MLHO R package to support further exploration of recurrent treatment and exposure patterns in various clinical settings.

  • Open Access

    Paxlovid shows organ-specific and age-specific impacts on risk of developing post-acute sequelae of COVID-19

    by Alaleh Azhir, Jingya Cheng, Jiazi Tian, Shawn N. Murphy, Hossein Estiri

    Background The impact of antiviral therapies, including Paxlovid, on post-acute sequelae of COVID-19 (PASC) remains inconclusive. Methods We analyzed data from 19,413 patients (age > 18) from a validated PASC research cohort in New England who experienced at least one COVID-19 infection episode between January 1, 2022, and June 7, 2022, totaling 22,094 episodes. Multivariable logistic regression with inverse probability weights was used to infer the causal effects of Paxlovid treatment during acute infection and the risk of PASC overall (primary outcome), stratified by age group and organ system. Results Across all age groups, Paxlovid shows no statistically significant effect in lowering overall PASC risk. Stratification by organ system reveals a 37% reduction in gastrointestinal PASC (OR: 0.63; 95% CI: [0.468, 0.850]; p < 0.05) but a 97.4% increase in the risk of eye and ear-related PASC (OR: 1.974; 95% CI: [1.048, 3.718]; p < 0.05). Among patients aged 65 to 75 years who were not hospitalized, Paxlovid is associated with a 16.8% reduction in PASC risk (OR: 0.832; 95% CI: [0.7, 0.989]; p < 0.05). No statistically significant effects is observed for other organ-specific outcomes. Conclusions Paxlovid demonstrates organ-specific effects on the risk of PASC, with a reduction in gastrointestinal symptoms and an increased risk of eye and ear-related symptoms. In older, non-hospitalized patients, Paxlovid modestly reduces overall PASC risk. These findings highlight the complexity of antiviral therapy’s long-term impact and underscore the need for further research to clarify the mechanisms underlying these outcomes.


  • Open Access

    Progressively Widening Healthcare Costs in Long COVID Over Five Years

    by Jingya Cheng, Alaleh Azhir, Jiazi Tian, Jeffrey G. Klann, Shawn N. Murphy, Hossein Estiri

    Background Long COVID affects millions worldwide, yet the long-term trajectory of healthcare costs remains poorly characterized. Prior studies with limited follow-up have documented elevated but stable excess costs, leaving uncertainty about whether the economic burden attenuates or persists over time. Methods We conducted a retrospective cohort study using electronic health record data from 12 hospitals and 20 community health centers (January 2018 through December 2024). Adults with documented SARS-CoV-2 infection were classified as having Long COVID using a validated precision phenotyping algorithm or as controls without Long COVID. We used two-part generalized estimating equation models to estimate adjusted quarterly healthcare costs over 20 quarters, decomposed costs into visit frequency and cost-per-visit components, and conducted subgroup and sensitivity analyses accounting for differential mortality. Results Among 143,544 adults (27,986 with Long COVID; 115,558 controls), the adjusted excess quarterly cost for Long COVID widened progressively rather than attenuating, increasing from $79 (95% CI, $48-$118) at baseline to $236 (95% CI, $176-$287) at quarter 19, a threefold increase in the cost differential. Long COVID was associated with 20% higher odds of any healthcare utilization (OR, 1.20; 95% CI, 1.18-1.23) and 30% higher costs when care was accessed (cost ratio, 1.30; 95% CI, 1.25-1.35). Visit frequency diverged over time, reaching 44% higher utilization by quarter 19, while cost-per-visit premiums remained stable. Excess costs concentrated in the upper distribution tail (99th percentile difference: $8,482). The widening trajectory was consistent across subgroups defined by hospitalization status, sex, and comorbidity burden. Cumulative 5-year excess costs were $7,124 per Long COVID patient after mortality adjustment. Conclusions Contrary to assumptions of post-acute recovery, Long COVID is associated with progressively widening healthcare costs over five years, driven primarily by increasing utilization rather than care intensity, suggesting an evolving chronic disease burden with substantial and growing economic implications.

  • Open Access

    The age paradox in post-infectious sequelae: physiological reserve outweighs chronological age in Long COVID susceptibility

    by Alaleh Azhir, Jingya Cheng, Jiazi Tian, Ingrid V. Bassett, Chirag J. Patel, Jeffrey G. Klann, Shawn N. Murphy, Hossein Estiri

    Background: Older age is widely considered a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC), typically attributed to immunosenescence and inflammaging. However, whether this association reflects intrinsic biological ageing or accumulated comorbidity burden remains unclear, with implications for clinical risk stratification. Methods: We conducted a retrospective cohort study using the Precision PASC Research Cohort (P2RC) from Mass General Brigham, comprising 133,792 COVID-19 patients from 12 hospitals and 20 community health centres in Massachusetts (March 2020-May 2024). PASC was ascertained using a validated computational phenotyping algorithm. We used generalised estimating equations with cluster-robust variance to model PASC risk, causal mediation analysis to decompose age effects through comorbidity burden and acute severity, and specification curve analysis across 768 analytical specifications to assess robustness. Findings: After adjustment for comorbidity burden, each decade of age was associated with 6% lower odds of PASC (OR 0.94; 95% CI 0.93-0.95). Causal mediation analysis revealed that comorbidities accounted for 145% of the total age effect, indicating inconsistent mediation wherein age’s direct protective effect was masked by its indirect harm through chronic disease accumulation. This protection was age-dependent: adults younger than 65 years retained robust resilience independent of comorbidities (ADE:-0.0042, p<0.001), whereas adults 65 years and older showed complete loss of this protection (ADE: +0.0020, p=0.14). Interpretation: Long COVID susceptibility is driven by physiological reserve rather than chronological age until approximately age 65, beyond which age-related protective mechanisms become exhausted. Risk stratification should prioritise comorbidity burden over birth year in younger adults. Funding: National Institute of Allergy and Infectious Diseases (NIAID).

  • Open Access

    Sequential Counterfactual Inference for Temporal Clinical Data: Addressing the Time Traveler Dilemma

    by Jingya Cheng, Alaleh Azhir, Jiazi Tian, Hossein Estiri

    Counterfactual inference enables clinicians to ask "what if" questions about patient outcomes, but standard methods assume feature independence and simultaneous modifiability -- assumptions violated by longitudinal clinical data. We introduce the Sequential Counterfactual Framework, which respects temporal dependencies in electronic health records by distinguishing immutable features (chronic diagnoses) from controllable features (lab values) and modeling how interventions propagate through time. Applied to 2,723 COVID-19 patients (383 Long COVID heart failure cases, 2,340 matched controls), we demonstrate that 38-67% of patients with chronic conditions would require biologically impossible counterfactuals under naive methods. We identify a cardiorenal cascade (CKD -> AKI -> HF) with relative risks of 2.27 and 1.19 at each step, illustrating temporal propagation that sequential -- but not naive -- counterfactuals can capture. Our framework transforms counterfactual explanation from "what if this feature were different?" to "what if we had intervened earlier, and how would that propagate forward?" -- yielding clinically actionable insights grounded in biological plausibility.

  • Open Access

    A retrieval-augmented generation large language model framework for accurate dementia identification from electronic health records

    by Liqin Wang, Baoren Liu, Richard Yang, Ya-Wen Chuang, Hossein Estiri, Shawn Murphy, Li Zhou, Gad A. Marshall

    Objective: Accurate and scalable dementia phenotyping from electronic health records (EHRs) is foundational for population-level research, risk prediction, and learning health system interventions. Traditional rule- and keyword-based approaches are limited by inconsistent documentation and inability to capture clinical nuance. We aim to develop and evaluate a framework that leverages large language models (LLMs) with retrieval-augmented generation (RAG) to overcome these limitations and improve dementia identification from real-world EHR data. Methods: Using EHR data from the Mass General Brigham health system, we first assembled a cohort of adults with potential dementia based on diagnosis codes, problem lists, dementia-related medications, and free-text note mentions. A subset of candidate cases underwent detailed manual chart review to assign gold-standard dementia status. With this labeled sample, we implemented and compared three approaches for dementia ascertainment: (1) a rule-based classifier leveraging structured EHR data, (2) large language models (LLMs) applied to keyword-filtered clinical note excerpts, and (3) a RAG-based LLM framework that integrates retrieved, context-rich note snippets. Within each approach, we evaluated multiple configurations of embedding models, retrieval methods, LLMs, structured-data inclusion, and prompts to identify the best-performing classifier. Performance was assessed using standard classification metrics, including sensitivity, specificity, positive predictive value (PPV), and F1 score, and supplemented by qualitative error analyses to characterize common sources of false positives and false negatives across methods. Results: The RAG-based classifier achieved the highest performance (F1=0.933, sensitivity=91.1%, PPV=95.5%) compared to rule-based (F1=0.823, sensitivity=81.1%, PPV=83.5%) and keyword-filtered LLM (F1=0.903, sensitivity=91.7%, PPV=88.6%). Including ICD codes alongside free text in the RAG-based LLM pipeline significantly reduced the PPV and modestly decreased F-1 score. Error analysis revealed that structured-code dependence contributed to false positives, whereas unrecognized contextual cues in notes drove false negatives. Conclusion: A RAG-based LLM pipeline without structured ICD codes improved dementia ascertainment from EHR data compared with ICD-based rules and keyword-based filtering. This approach can enhance dementia case identification and support patient care, predictive modeling and risk analysis.